David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRMN
626
Garmin
GRMN
$56.5B
| $15.9M | 0.03% |
397,801
+216,320
| +119% | +$8.03M |
|
|
MNTA
627
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $15.9M | 0.03% |
1,717,396
+138,900
| +9% | +$1.49M |
|
628
CALL
American International
AIG
$40.5B
| $15.9M | 0.03% |
293,400
+99,900
| +52% | +$5.4M |
|
629
Darling Ingredients
DAR
$9.86B
| $15.8M | 0.03% |
1,200,245
+803,736
| +203% | +$8.1M |
|
|
CPGX
630
DELISTED
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
| $15.8M | 0.03% |
629,411
-1,552,197
| -71% | -$30.1M |
|
631
Federated Hermes
FHI
$4.81B
| $15.7M | 0.03% |
545,763
+114,912
| +27% | +$3.02M |
|
632
Fossil Group
FOSL
$332M
| $15.7M | 0.03% |
353,231
+307,167
| +667% | +$12.1M |
|
|
KS
633
DELISTED
KapStone Paper and Pack Corp.
KS
| $15.7M | 0.03% |
1,132,272
-1,219,254
| -52% | -$16.5M |
|
|
RPAI
634
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $15.7M | 0.03% |
988,958
-70,991
| -7% | -$1.07M |
|
635
National Grid
NGG
$80.8B
| $15.6M | 0.03% |
+226,683
| New | +$15.1M |
|
636
PUT
Alcoa
AA
$13.1B
| $15.5M | 0.03% |
673,824
-205,535
| -23% | -$4.18M |
|
|
EA
637
DELISTED
Electronic Arts
EA
| $15.4M | 0.03% |
232,906
-1,630,295
| -87% | -$104M |
|
|
GWB
638
DELISTED
Great Western Bancorp, Inc.
GWB
| $15.3M | 0.03% |
562,649
+73,634
| +15% | +$1.89M |
|
639
Goodyear
GT
$1.7B
| $15.3M | 0.03% |
463,875
+379,600
| +450% | +$11.4M |
|
|
IM
640
DELISTED
Ingram Micro
IM
| $15.3M | 0.03% |
425,457
+98,376
| +30% | +$3.15M |
|
|
641
PUT
American International
AIG
$40.5B
| $15.3M | 0.03% |
282,500
+97,000
| +52% | +$5.24M |
|
642
Best Buy
BBY
$18.6B
| $15.2M | 0.03% |
+469,438
| New | +$14.2M |
|
|
DGI
643
DELISTED
DigitalGlobe Inc.
DGI
| $15.1M | 0.03% |
874,583
-232,525
| -21% | -$3.47M |
|
|
CCP
644
DELISTED
Care Capital Properties, Inc.
CCP
| $15.1M | 0.03% |
562,033
+235,021
| +72% | +$6.51M |
|
645
AutoNation
AN
$6.52B
| $15M | 0.03% |
320,761
+248,909
| +346% | +$12.1M |
|
646
PTC
PTC
$16.8B
| $15M | 0.03% |
451,415
+245,879
| +120% | +$7.59M |
|
|
SYNH
647
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $14.9M | 0.03% |
361,669
+22,093
| +7% | +$911K |
|
648
Ingredion
INGR
$6.72B
| $14.9M | 0.03% |
139,203
+113,587
| +443% | +$11.3M |
|
649
Steris
STE
$23.1B
| $14.8M | 0.03% |
208,796
| – | – |
|
650
PUT
Deere & Co
DE
$176B
| $14.8M | 0.03% |
191,700
-84,700
| -31% | -$6.63M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.